Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO Study.
Lopes SS, Heo M, Pericot-Valverde I, Norton BL, Taylor LE, Tsui JI, Mehta SH, Feinberg J, Kim AY, Lum PJ, Page K, Murray-Krezan C, Anderson J, Litwin AH, The Hero Study Group. Lopes SS, et al. Among authors: page k. Viruses. 2024 Sep 30;16(10):1551. doi: 10.3390/v16101551. Viruses. 2024. PMID: 39459883 Free PMC article. Clinical Trial.
Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder.
Evans SK, Ober AJ, Korn AR, Peltz A, Friedmann PD, Page K, Murray-Krezan C, Huerta S, Ryzewicz SJ, Tarhuni L, Nuckols TK, E Watkins K, Danovitch I. Evans SK, et al. Among authors: page k. Addict Sci Clin Pract. 2024 Apr 26;19(1):31. doi: 10.1186/s13722-024-00461-x. Addict Sci Clin Pract. 2024. PMID: 38671482 Free PMC article. Clinical Trial.
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cure.
Lopes SS, Pericot-Valverde I, Dotherow JE, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Karasz A, Arnsten J, Moschella P, Heo M, Litwin AH; HERO study group. Lopes SS, et al. Among authors: page k. Drug Alcohol Depend. 2024 Sep 1;262:111384. doi: 10.1016/j.drugalcdep.2024.111384. Epub 2024 Jul 6. Drug Alcohol Depend. 2024. PMID: 38991632
Hepatitis C Virus Reinfection Among People Who Inject Drugs: Long-Term Follow-Up of the HERO Study.
Litwin AH, Tsui JI, Heo M, Mehta SH, Taylor LE, Lum PJ, Feinberg J, Kim AY, Norton BL, Pericot-Valverde I, Arnsten J, Meissner P, Karasz A, McKee MD, Ward JW, Johnson N, Agyemang L, Stein ES, Thomas A, Borsuk C, Blalock KL, Wilkinson S, Wagner K, Carty J, Murray-Krezan C, Anderson J, Jacobsohn V, Luetkemeyer AF, Falade-Nwulia O, Groome M, Davies S, Costello K, Page K; HERO Study Group. Litwin AH, et al. Among authors: page k. JAMA Netw Open. 2024 Aug 1;7(8):e2430024. doi: 10.1001/jamanetworkopen.2024.30024. JAMA Netw Open. 2024. PMID: 39186268 Free article. Clinical Trial.
Finding the right dose: a scoping review examining facilitation as an implementation strategy for evidence-based stroke care.
Fasugba O, Cheng H, Dale S, Coughlan K, McInnes E, Cadilhac DA, Cheung NW, Hill K, Page K, Menendez ES, Neal E, Pollnow V, Slark J, Gilder E, Ranta A, Levi C, Grimshaw JM, Middleton S. Fasugba O, et al. Among authors: page k. Implement Sci. 2025 Jan 13;20(1):4. doi: 10.1186/s13012-025-01415-w. Implement Sci. 2025. PMID: 39806380 Free article. Review.
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Fiorentino D, Mangold AR, Werth VP, Christopher-Stine L, Femia A, Chu M, Musiek ACM, Sluzevich JC, Graham LV, Fernandez AP, Aggarwal R, Rieger K, Page KM, Li X, Hyde C, Rath N, Sloan A, Oemar B, Banerjee A, Salganik M, Banfield C, Neelakantan S, Beebe JS, Vincent MS, Peeva E, Vleugels RA. Fiorentino D, et al. Among authors: page km. Lancet. 2025 Jan 11;405(10473):137-146. doi: 10.1016/S0140-6736(24)02071-3. Lancet. 2025. PMID: 39798982 Clinical Trial.
1,284 results